BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19541857)

  • 21. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
    Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
    J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coffee intake and breast cancer risk in the NIH-AARP diet and health study cohort.
    Gierach GL; Freedman ND; Andaya A; Hollenbeck AR; Park Y; Schatzkin A; Brinton LA
    Int J Cancer; 2012 Jul; 131(2):452-60. PubMed ID: 22020403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effect between alcohol and estrogen replacement therapy on risk of breast cancer differs by estrogen/progesterone receptor status in the Iowa Women's Health Study.
    Gapstur SM; Potter JD; Drinkard C; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):313-8. PubMed ID: 7655324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary fiber intake and risk of postmenopausal breast cancer defined by estrogen and progesterone receptor status--a prospective cohort study among Swedish women.
    Suzuki R; Rylander-Rudqvist T; Ye W; Saji S; Adlercreutz H; Wolk A
    Int J Cancer; 2008 Jan; 122(2):403-12. PubMed ID: 17764112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer.
    Lænkholm AV; Jensen MB; Eriksen JO; Roslind A; Buckingham W; Ferree S; Nielsen T; Ejlertsen B
    Clin Breast Cancer; 2020 Aug; 20(4):e423-e432. PubMed ID: 32253134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.
    Farhat GN; Cummings SR; Chlebowski RT; Parimi N; Cauley JA; Rohan TE; Huang AJ; Vitolins M; Hubbell FA; Manson JE; Cochrane BB; Lane DS; Lee JS
    J Natl Cancer Inst; 2011 Apr; 103(7):562-70. PubMed ID: 21330633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foods, macronutrients and breast cancer risk in postmenopausal women: a large UK cohort.
    Key TJ; Balkwill A; Bradbury KE; Reeves GK; Kuan AS; Simpson RF; Green J; Beral V
    Int J Epidemiol; 2019 Apr; 48(2):489-500. PubMed ID: 30412247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basal-like immunophenotype markers and prognosis in early breast cancer.
    Cassol L; Silveira Graudenz M; Zelmanowicz A; Cancela A; Werutsky G; Rovere RK; Garicochea B
    Tumori; 2010; 96(6):966-70. PubMed ID: 21388060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women.
    Li CI; Weiss NS; Stanford JL; Daling JR
    Cancer; 2000 Jun; 88(11):2570-7. PubMed ID: 10861435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective study of physical activity and risk of postmenopausal breast cancer.
    Leitzmann MF; Moore SC; Peters TM; Lacey JV; Schatzkin A; Schairer C; Brinton LA; Albanes D
    Breast Cancer Res; 2008; 10(5):R92. PubMed ID: 18976449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of heat shock protein 10 correlates negatively with estrogen/progesterone receptor status and predicts poor prognosis in invasive ductal breast carcinoma.
    Chu S; Wen Q; Qing Z; Luo J; Wang W; Chen L; Feng J; Xu L; Zang H; Fan S
    Hum Pathol; 2017 Mar; 61():173-180. PubMed ID: 27993580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
    Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Cushing-Haugen KL; Daling JR
    JAMA; 2003 Jun; 289(24):3254-63. PubMed ID: 12824206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
    Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
    Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
    [No Abstract]   [Full Text] [Related]  

  • 36. Physical activity and postmenopausal breast cancer risk in the NIH-AARP diet and health study.
    Peters TM; Schatzkin A; Gierach GL; Moore SC; Lacey JV; Wareham NJ; Ekelund U; Hollenbeck AR; Leitzmann MF
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):289-96. PubMed ID: 19124511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcohol drinking, ADH1B and ADH1C genotypes and the risk of postmenopausal breast cancer by hormone receptor status: the Netherlands Cohort Study on diet and cancer.
    Hahn M; Simons CCJM; Weijenberg MP; van den Brandt PA
    Carcinogenesis; 2018 Dec; 39(11):1342-1351. PubMed ID: 30052783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmenopausal breast cancer risk and dietary patterns in the E3N-EPIC prospective cohort study.
    Cottet V; Touvier M; Fournier A; Touillaud MS; Lafay L; Clavel-Chapelon F; Boutron-Ruault MC
    Am J Epidemiol; 2009 Nov; 170(10):1257-67. PubMed ID: 19828509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alcohol consumption and breast cancer: estrogen receptor status and histology.
    Nasca PC; Liu S; Baptiste MS; Kwon CS; Jacobson H; Metzger BB
    Am J Epidemiol; 1994 Dec; 140(11):980-8. PubMed ID: 7985660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort.
    Brinton LA; Richesson D; Leitzmann MF; Gierach GL; Schatzkin A; Mouw T; Hollenbeck AR; Lacey JV
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3150-60. PubMed ID: 18990757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.